Clinical Microbiology Market Revenue Analysis By Product, By Application And Segment Forecasts To 2024

  • ID: 3934175
  • Report
  • 90 pages
  • Grand View Research
1 of 3
The global clinical microbiology market was valued at USD 8.4 billion in 2015 and is expected to reach a value of USD 16.1 billion by 2024. Key factors driving the market growth include constant introduction of advanced products coupled with increasing demand in pharmaceutical, and clinical applications for investigation and diagnosis of various infectious diseases.

The market is rapidly growing due to the increasing adoption of automated and advanced technologies for laboratory instruments and analyzers in developed countries. Growing geriatric population and thereby rising prevalence of infectious diseases is one of the major factors boosting the adoption of clinical microbiology in healthcare sector for disease diagnosis and monitoring. In addition, industry is gaining high momentum with launch of innovative products such as MALDI Biotyper, GeneXpert and Myla IT performance management solutions. Moreover, with the U.S. FDA approving the Xpert Carba-R, commercialization of clinical microbiology devices is expected to increase significantly over the next few years.

In North America, the government authorities and private companies have significantly contributed toward technology development, research funding, and commercialization of clinical microbiology associated devices.

Further Key Findings from the Study Suggest:

Rapid adoption of technology and automation of laboratory work flow, laboratory instrument segement is expected to be the fastest growing segment with CAGR of 8.6% over the forecast period.

Reagents is the largest segment with market share of 34.7% in 2015. Repeat purchase of reagents contribute to its growth thus it is the largest growing segment in market.

In 2015, North America dominated the global market with largest revenue share of 41.0%. The continuous research on infectious disease treatment, and subsequent grant from government healthcare agencies are contributing to the development of a strong ecosystem for the expansion of clinical microbiology in the region.

Asia Pacific is expected to emerge as the fastest growing region during the forecast period. The growing geriatric population in India, China and Japan leading to increase in the prevalence of re-emerging infectious diseases such as tuberculosis, cholera and typhoid in this region are expected to promote the utilization of clinical application of microbiology in healthcare.

The clinical microbiology Industry is presently dominated by a few key participants such as bioMerieux S.A., Cepheid Inc., Danaher Corporation and Bruker Corporation. Some of the prominent players operating in the market include but are not limited to Becton Dickinson & Company, Hologic Inc., Roche Diagnostics and Alere Inc. Introduction of automated systems and innovative designs, is expected to intensify the competition by changing the market dynamics over the forecast period.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1 Research Methodology
1.1 Information procurement
1.2 Data Analysis
1.3 Approaches for market estimation
1.3.1 Approach 1: Demand Analysis & Bottom up Approach
1.3.2 Approach 2: Top down market estimation
1.3.3 Approach 3: Commodity flow and bottom up market estimation
1.3.4 Approach 4: KoL perspective based market sizing
2 Executive Summary
3 Market Snapshot
4 Market Variables, Trends & Scope
4.1 Market segmentation & scope
4.1.1 Market Driver Analysis
4.1.1.1 Demand for automated platform
4.1.1.2 Increasing prevalence of infectious diseases
4.1.2 Market Restraints Analysis
4.1.2.1 Lack of skilled professionals
4.1.2.2 Reimbursement concerns and unfavorable regulatory scenario
4.2 Penetration & growth prospect mapping
4.3 Clinical Microbiology - SWOT Analysis, By Factor (political & legal, economic and technological)
4.4 Industry Analysis - Porter’s
5 Market Categorization 1: Product Estimates & Trend Analysis
5.1 Clinical Microbiology Market: Product movement analysis
5.2 Laboratory Instruments
5.2.1 Laboratory Instruments Market, 2014 - 2024 (USD Million)
5.2.2 Incubators
5.2.3 Gram Stainers
5.2.4 Bacterial Colony Counters
5.2.5 Autoclave Sterilizers
5.2.6 Petri Dish Fillers
5.2.7 Culture Systems
5.3 Microbiology Analyzers
5.3.1 Microbiology Analyzers market, 2014 - 2024 (USD Million)
5.3.2 Molecular Diagnostics Instruments
5.3.3 Microscopes
5.3.4 Mass Spectrometers
5.4 Reagents
5.4.1 Reagents Market, 2014 - 2024 (USD Million)
6 Market Categorization 2: Application Estimates & Trend Analysis
6.1 Clinical Microbiology Market: Disease movement analysis
6.2 Respiratory Diseases
6.2.1 Respiratory Diseases Market, 2014 - 2024 (USD Million)
6.3 Bloodstream Infections
6.3.1 Bloodstream Infections Market, 2014 - 2024 (USD Million)
6.4 Gastrointestinal Diseases
6.4.1 Gastrointestinal Diseases Market, 2014 - 2024 (USD Million)
6.5 Sexually transmitted Diseases
6.5.1 Sexually transmitted Diseases Market, 2014 - 2024 (USD Million)
6.6 Urinary Tract Infections
6.6.1 Urinary Tract Infections Market, 2014 - 2024 (USD Million)
6.7 Periodontal Diseases
6.7.1 Periodontal Diseases Market, 2014 - 2024 (USD Million)
7 Market Categorization 3: Regional Estimates & Trend Analysis, by Product & Application type
7.1 North America
7.1.1 U.S.
7.1.2 Canada
7.2 Europe
7.2.1 U.K.
7.2.2 Germany
7.3 Asia Pacific
7.3.1 Japan
7.3.2 China
7.3.3 India
7.4 Latin America
7.4.1 Brazil
7.4.2 Mexico
7.5 Middle East and Africa (MEA)
7.5.1 South Africa
8 Competitive Landscape
8.1 Market participation categorization
8.2 Company Profiles
8.2.1 bioMerieux S.A.
8.2.1.1 Company Overview
8.2.1.2 Financial Performance
8.2.1.3 Product Benchmarking
8.2.1.4 Strategic Initiatives
8.2.2 Abbott Laboratories
8.2.2.1 Company Overview
8.2.2.2 Financial Performance
8.2.2.3 Product Benchmarking
8.2.2.4 Strategic Initiatives
8.2.3 Roche Diagnostics
8.2.3.1 Company Overview
8.2.3.2 Financial Performance
8.2.3.3 Product Benchmarking
8.2.3.4 Strategic Initiatives
8.2.4 Bruker Corporation
8.2.4.1 Company Overview
8.2.4.2 Financial Performance
8.2.4.3 Product Benchmarking
8.2.4.4 Strategic Initiatives
8.2.5 Alere Inc.
8.2.5.1 Company Overview
8.2.5.2 Financial Performance
8.2.5.3 Product Benchmarking
8.2.5.4 Strategic Initiatives
8.2.6 Cepheid Inc.
8.2.6.1 Company Overview
8.2.6.2 Financial Performance
8.2.6.3 Product Benchmarking
8.2.6.4 Strategic Initiatives
8.2.7 Bio-Rad Laboratories Inc.
8.2.7.1 Company Overview
8.2.7.2 Financial Performance
8.2.7.3 Product Benchmarking
8.2.7.4 Strategic Initiatives
8.2.8 Becton Dickinson and Company
8.2.8.1 Company Overview
8.2.8.2 Financial Performance
8.2.8.3 Product Benchmarking
8.2.8.4 Strategic Initiatives
8.2.9 Hologic Inc.
8.2.9.1 Company Overview
8.2.9.2 Financial Performance
8.2.9.3 Product Benchmarking
8.2.9.4 Strategic Initiatives

List of Tables

Table 1 North America Clinical Microbiology Market, by Product, 2014 - 2024 (USD Million)
Table 2 North America Clinical Microbiology market, by Laboratory Instruments, 2014 - 2024 (USD Million)
Table 3 North America Clinical Microbiology market, by Microbiology Analyzers, 2014 - 2024 (USD Million)
Table 4 North America Clinical Microbiology Market, by Application, 2014 - 2024 (USD Million)
Table 5 U.S.Clinical MicrobiologyMarket, by Product, 2014 - 2024 (USD Million)
Table 6 U.S.Clinical MicrobiologyMarket, by Laboratory Instruments, 2014 - 2024 (USD Million)
Table 7 U.S. Clinical Microbiology Market, by Microbiology Analyzers, 2014 - 2024 (USD Million)
Table 8 U.S. Clinical Microbiology Market, by Application, 2014 - 2024 (USD Million)
Table 9 Canada Clinical Microbiology Market, by Product, 2014 - 2024 (USD Million)
Table 10 Canada Clinical Microbiology Market, by Laboratory Instruments, 2014 - 2024 (USD Million)
Table 11 Canada Clinical Microbiology Market, by Microbiology Analyzers, 2014 - 2024 (USD Million)
Table 12 Canada Clinical Microbiology Market, by Application, 2014 - 2024 (USD Million)
Table 13 Europe Clinical Microbiology Market, by Product, 2014 - 2024 (USD Million)
Table 14 Europe Clinical Microbiology Market, by Laboratory Instruments, 2014 - 2024 (USD Million)
Table 15 Europe Clinical Microbiology Market, by Microbiology Analyzers, 2014 - 2024 (USD Million)
Table 16 Europe Clinical Microbiology Market, by Application, 2014 - 2024 (USD Million)
Table 17 U.K. Clinical Microbiology Market, by Product, 2014 - 2024 (USD Million)
Table 18 U.K. Clinical Microbiology Market, by Laboratory Instruments, 2014 - 2024 (USD Million)
Table 19 U.K.Clinical MicrobiologyMarket, by Microbiology Analyzers, 2014 - 2024 (USD Million)
Table 20 U.K Clinical Microbiology Market, by Application, 2014 - 2024 (USD Million)
Table 21 Germany Clinical Microbiology Market, by Product, 2014 - 2024 (USD Million)
Table 22 Germany Clinical Microbiology Market, by Laboratory Instruments, 2014 - 2024 (USD Million)
Table 23 Germany Clinical Microbiology Market, by Microbiology Analyzers, 2014 - 2024 (USD Million)
Table 24 Germany Clinical Microbiology Market, by Application, 2014 - 2024 (USD Million)
Table 25 Asia Pacific Clinical Microbiology Market, by Product, 2014 - 2024 (USD Million)
Table 26 Asia Pacific Clinical Microbiology Market, by Laboratory Instruments, 2014 - 2024 (USD Million)
Table 27 Asia Pacific Clinical Microbiology Market, by Microbiology Analyzers, 2014 - 2024 (USD Million)
Table 28 Asia Pacific Clinical Microbiology Market, by Application, 2014 - 2024 (USD Million)
Table 29 Japan Clinical Microbiology Market, by Product, 2014 - 2024 (USD Million)
Table 30 Japan Clinical Microbiology Market, by Laboratory Instruments, 2014 - 2024 (USD Million)
Table 31 Japan Clinical Microbiology Market, by Microbiology Analyzers, 2014 - 2024 (USD Million)
Table 32 Japan Clinical Microbiology Market, by Application, 2014 - 2024 (USD Million)
Table 33 China Clinical Microbiology Market, by Product, 2014 - 2024 (USD Million)
Table 34 China Clinical Microbiology Market, by Laboratory Instruments, 2014 - 2024 (USD Million)
Table 35 China Clinical Microbiology Market, by Microbiology Analyzers, 2014 - 2024 (USD Million)
Table 36 China Clinical Microbiology Market, by Application, 2014 - 2024 (USD Million)
Table 37 India Clinical Microbiology Market, by Product, 2014 - 2024 (USD Million)
Table 38 India Clinical Microbiology Market, by Laboratory Instruments, 2014 - 2024 (USD Million)
Table 39 India Clinical Microbiology Market, by Microbiology Analyzers, 2014 - 2024 (USD Million)
Table 40 India Clinical Microbiology Market, by Application, 2014 - 2024 (USD Million)
Table 41 Latin America Clinical Microbiology Market, by Product, 2014 - 2024 (USD Million)
Table 42 Latin America Clinical Microbiology Market, by Laboratory Instruments, 2014 - 2024 (USD Million)
Table 43 Latin America Clinical Microbiology Market, by Microbiology Analyzers, 2014 - 2024 (USD Million)
Table 44 Latin America Clinical Microbiology Market, by Application, 2014 - 2024 (USD Million)
Table 45 Brazil Clinical Microbiology Market, by Product, 2014 - 2024 (USD Million)
Table 46 Brazil Clinical Microbiology Market, by Laboratory Instruments, 2014 - 2024 (USD Million)
Table 47 Brazil Clinical Microbiology Market, by Microbiology Analyzers, 2014 - 2024 (USD Million)
Table 48 Brazil Clinical Microbiology Market, by Application, 2014 - 2024 (USD Million)
Table 49 Mexico Clinical Microbiology Market, by Product, 2014 - 2024 (USD Million)
Table 50 Mexico Clinical Microbiology Market, by Laboratory Instruments, 2014 - 2024 (USD Million)
Table 51 Mexico Clinical Microbiology Market, by Microbiology Analyzers, 2014 - 2024 (USD Million)
Table 52 Mexico Clinical Microbiology Market, by Application 2014 - 2024 (USD Million)
Table 53 MEA Clinical Microbiology Market, by Product, 2014 - 2024 (USD Million)
Table 54 MEA Clinical Microbiology Market, by Laboratory Instruments, 2014 - 2024 (USD Million)
Table 55 MEA Clinical Microbiology Market, by Microbiology Analyzers, 2014 - 2024 (USD Million)
Table 56 MEA Clinical Microbiology Market, by Application, 2014 - 2024 (USD Million)
Table 57 South Africa Clinical Microbiology Market, by Product, 2014 - 2024 (USD Million)
Table 58 South Africa Clinical Microbiology Market, by Laboratory Instruments, 2014 - 2024 (USD Million)
Table 59 South Africa Clinical Microbiology Market, by Microbiology Analyzers, 2014 - 2024 (USD Million)
Table 60 South Africa Clinical Microbiology Market, by Application, 2014 - 2024 (USD Million)

List of Figures

Figure 1 Market research process
Figure 2 Information procurement
Figure 3 Primary research pattern
Figure 4 Market research approaches
Figure 5 Value chain based sizing & forecasting
Figure 6 QFD modelling for market share assessment
Figure 7 Market summary
Figure 8 Market trends & outlook
Figure 9 Market segmentation & scope
Figure 10 Market driver relevance analysis (Current & future impact)
Figure 11 Global Aging Population Demographics, 2015 & 2050
Figure 12 Market driver relevance analysis (Current & future impact)
Figure 13 Penetration & Growth prospect mapping
Figure 14 SWOT Analysis, By Factor (political & legal, economic and technological)
Figure 15 Porter’s Five Forces Analysis
Figure 16 Clinical Microbiology market product outlook key takeaways
Figure 17 Clinical Microbiology: Product movement analysis
Figure 18 Laboratory Instruments Market, 2014 - 2024 (USD Million)
Figure 19 Incubators Market, 2014 - 2024 (USD Million)
Figure 20 Gram Stainers Market, 2014 - 2024 (USD Million)
Figure 21 Bacterial Colony CountersMarket, 2014 - 2024 (USD Million)
Figure 22 Autoclave Sterilizers Market, 2014 - 2024 (USD Million)
Figure 23 Petri Dish Fillers Market, 2014 - 2024 (USD Million)
Figure 24 Culture SystemsMarket, 2014 - 2024 (USD Million)
Figure 25 Microbiology Analyzers Market, 2014 - 2024 (USD Million)
Figure 26 Molecular Diagnostics Instruments Market, 2014 - 2024 (USD Million)
Figure 27 Microscopes Market, 2014 - 2024 (USD Million)
Figure 28 Mass Spectrometers Market, 2014 - 2024 (USD Million)
Figure 29 Reagents Market, 2014 - 2024 (USD Million)
Figure 30 Clinical Microbiology market disease outlook key takeaways
Figure 31 Clinical Microbiology: Application movement analysis
Figure 32 Respiratory Diseases Market, 2014 - 2024 (USD Million)
Figure 33 Bloodstream Infections Market, 2014 - 2024 (USD Million)
Figure 34 Gastrointestinal Diseases Market, 2014 - 2024 (USD Million)
Figure 35 Sexually transmitted Diseases Market, 2014 - 2024 (USD Million)
Figure 36 Urinary Tract Infections Market, 2014 - 2024 (USD Million)
Figure 37 Periodontal Diseases Market, 2014 - 2024 (USD Million)
Figure 38 Regional market place: Key takeaways
Figure 39 Strategy framework
Figure 40 Participant categorization
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll